Logo image of GP

GREENPOWER MOTOR CO INC (GP) Stock Fundamental Analysis

NASDAQ:GP - CA39540E3023 - Common Stock

0.3438 USD
-0.01 (-2.66%)
Last: 8/26/2025, 8:00:01 PM
0.3438 USD
0 (0%)
Pre-Market: 8/27/2025, 7:07:12 AM
Fundamental Rating

1

Overall GP gets a fundamental rating of 1 out of 10. We evaluated GP against 127 industry peers in the Machinery industry. GP may be in some trouble as it scores bad on both profitability and health. GP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GP had negative earnings in the past year.
GP had a negative operating cash flow in the past year.
GP had negative earnings in each of the past 5 years.
GP had a negative operating cash flow in each of the past 5 years.
GP Yearly Net Income VS EBIT VS OCF VS FCFGP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M

1.2 Ratios

With a Return On Assets value of -52.31%, GP is not doing good in the industry: 88.98% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -52.31%
ROE N/A
ROIC N/A
ROA(3y)-39.16%
ROA(5y)-33.5%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GP Yearly ROA, ROE, ROICGP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K 4K 5K

1.3 Margins

Looking at the Gross Margin, with a value of 12.70%, GP is doing worse than 86.61% of the companies in the same industry.
In the last couple of years the Gross Margin of GP has declined.
GP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.05%
GM growth 5Y-18.09%
GP Yearly Profit, Operating, Gross MarginsGP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5K -10K -15K -20K -25K

More info and screens

0

2. Health

2.1 Basic Checks

GP does not have a ROIC to compare to the WACC, probably because it is not profitable.
GP has more shares outstanding than it did 1 year ago.
The number of shares outstanding for GP has been increased compared to 5 years ago.
The debt/assets ratio for GP is higher compared to a year ago.
GP Yearly Shares OutstandingGP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
GP Yearly Total Debt VS Total AssetsGP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -4.32, we must say that GP is in the distress zone and has some risk of bankruptcy.
GP has a worse Altman-Z score (-4.32) than 88.98% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.32
ROIC/WACCN/A
WACC7.99%
GP Yearly LT Debt VS Equity VS FCFGP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M -20M 30M

2.3 Liquidity

A Current Ratio of 1.29 indicates that GP should not have too much problems paying its short term obligations.
GP has a Current ratio of 1.29. This is amonst the worse of the industry: GP underperforms 82.68% of its industry peers.
A Quick Ratio of 0.07 indicates that GP may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.07, GP is doing worse than 96.06% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 0.07
GP Yearly Current Assets VS Current LiabilitesGP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 24.39% over the past year.
GP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.47%.
The Revenue has been growing by 8.01% on average over the past years. This is quite good.
EPS 1Y (TTM)24.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)-25.47%
Revenue growth 3Y4.81%
Revenue growth 5Y8.01%
Sales Q2Q%-48.3%

3.2 Future

The Earnings Per Share is expected to grow by 25.18% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 70.92% on average over the next years. This is a very strong growth
EPS Next Y16.41%
EPS Next 2Y25.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year52.4%
Revenue Next 2Y70.92%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GP Yearly Revenue VS EstimatesGP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
GP Yearly EPS VS EstimatesGP Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

GP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GP Price Earnings VS Forward Price EarningsGP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GP Per share dataGP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as GP's earnings are expected to grow with 25.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.18%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREENPOWER MOTOR CO INC

NASDAQ:GP (8/26/2025, 8:00:01 PM)

Premarket: 0.3438 0 (0%)

0.3438

-0.01 (-2.66%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)11-12 2025-11-12
Inst Owners3.91%
Inst Owner Change6.8%
Ins Owners22.12%
Ins Owner ChangeN/A
Market Cap10.47M
Analysts84.44
Price Target1.28 (272.31%)
Short Float %2.36%
Short Ratio0.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.25%
Min EPS beat(2)9.39%
Max EPS beat(2)21.12%
EPS beat(4)3
Avg EPS beat(4)8.35%
Min EPS beat(4)-0.03%
Max EPS beat(4)21.12%
EPS beat(8)4
Avg EPS beat(8)-10.02%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-62.38%
Min Revenue beat(2)-80.96%
Max Revenue beat(2)-43.79%
Revenue beat(4)1
Avg Revenue beat(4)-26.8%
Min Revenue beat(4)-80.96%
Max Revenue beat(4)24.04%
Revenue beat(8)1
Avg Revenue beat(8)-32.83%
Revenue beat(12)3
Avg Revenue beat(12)-19.69%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.11%
EPS NQ rev (1m)-21.74%
EPS NQ rev (3m)-21.74%
EPS NY rev (1m)-17.89%
EPS NY rev (3m)-17.89%
Revenue NQ rev (1m)-23.64%
Revenue NQ rev (3m)-23.64%
Revenue NY rev (1m)-20.5%
Revenue NY rev (3m)-20.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.57
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.62
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0.6
BVpS-0.17
TBVpS-0.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -52.31%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.7%
FCFM N/A
ROA(3y)-39.16%
ROA(5y)-33.5%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.05%
GM growth 5Y-18.09%
F-Score2
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.31%
Cap/Sales 0.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 0.07
Altman-Z -4.32
F-Score2
WACC7.99%
ROIC/WACCN/A
Cap/Depr(3y)17.9%
Cap/Depr(5y)43.07%
Cap/Sales(3y)0.75%
Cap/Sales(5y)1.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y16.41%
EPS Next 2Y25.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.47%
Revenue growth 3Y4.81%
Revenue growth 5Y8.01%
Sales Q2Q%-48.3%
Revenue Next Year52.4%
Revenue Next 2Y70.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.06%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-93.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-118.39%
OCF growth 3YN/A
OCF growth 5YN/A